ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,420, issued on May 19, was assigned to SANOFI (Paris).
"CXCR5 antibody formulations" was invented by Donny Francis (Frankfurt am Main, Germany), Ahmed Youssef (Frankfurt am Main, Germany), Stefaniya Korueva (Frankfurt am Main, Germany) and Martina Kirsch (Frankfurt am Main, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "High concentration antibody formulations capable of stable long-term storage are disclosed."
The patent was filed on Dec. 27, 2021, under Application No. 17/562,480.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml...